UBS Group AG (NYSE:UBS) shares traded lower over the last trading session, losing -1.09% on 06/09/21. The shares fell to a low of $16.25 before closing at $16.27. Intraday shares traded counted 1.57 million, which was 43.03% higher than its 30-day average trading volume of 2.76M. UBS’s previous close was $16.45 while the outstanding shares total 3.54B. The firm has a beta of 1.18, a 12-month trailing P/E ratio of 8.88, and a growth ratio of 3.24. The stock’s Relative Strength Index (RSI) is 58.07, with weekly volatility at 0.83% and ATR at 0.23. The UBS stock’s 52-week price range has touched low of $10.14 and a $16.58 high.
Investors have identified the Banks – Diversified company UBS Group AG as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $63.00 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Having a look at the companyâ€™s valuation, the company is expected to record 1.62 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on UBS sounds very interesting.
Is the stock of UBS attractive?
In related news, 10% Owner, UBS Group AG bought 450 shares of the companyâ€™s stock in a transaction that recorded on Feb 05. The purchase was performed at an average price of 5.87, for a total value of 2,643. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.05%.
12 out of 21 analysts covering the stock have rated it a Buy, while 7 have maintained a Hold recommendation on UBS Group AG. 1 analysts has assigned a Sell rating on the UBS stock. The 12-month mean consensus price target for the companyâ€™s shares has been set at $17.91.